SMR CPST TAT

ve tbe ee at awe

ut approximately 4,200 rad (600 rad
x 7) in I equivalents from shortlived iodine isotopes. Such a “correction” could well make the high prevalence

of

hypothyroidism

in

the

exposed Marshallese more in keeping
with the expectations from the experience with therapeutic '"I.
Several other factors may be contributing to the fact that the prevalence of hypothyroidism in this population is greater than is observed

after '"I exposure. The estimates of
thyroid exposure, particularly that
due to the short-lived isotopes of
iodine, is only approximate for the
reasons already discussed and could
have been underestimated. A reevalu-

ation of these calculations is currently under way at Brookhaven National

aa othe Me

the patients at highest risk, it is

Laboratory. Second, the hypothyroid-

considerable. From the results in
Table 3, one must even consider the

ism on which the risk estimates are

based has largely been overt, whereas
the present study has employed sensi-

possibility that an elevation in the

"TSH level could have contributed to
the development of the early thyroid

tive biochemical -techniques not generally used in previous studies. A
third consideration is that the early
and severe thyroid dysfunction accurred in persons exposed as very
youngchildren, whereastherisk estimates are based almost exclusively on
data obtained in adults with hyperthyroidism. The radiosensitivity of

nodularity. Such a possibility justifies

the prophylactic administration of
levothyroxine sodium in the exposed
Rongelap and Ailingnae population.
The high frequency of delayed thyroid disease after a nuclear explosion

over 100 miles distant is striking.

Continued careful medical observation of the exposed Marshallese will
be required for the possible development of hypothyroidism, as well as
thyroid nodularity.

the young thyroid, at least for neo-

plastic changes, is greater than that
in older persons.’ Whatever the reason(s), it is apparent that, while the

true prevalence of hypothyroidism is
not definable in this population
‘because of thyroid surgery in many of
References

1. Robbins J, Rall JE, Conard RA: Late effects
of radioactive iodine in fallout, Combined Clinical Staff Conference at the National Institutes of
Health. Ann Intern Med 1967;66:1214-1240.
2. Conard RA, Knudsen KD, Dobyns BM, et ak

roid disease: A controlled study. JAMA 1980;
244:1802-1805.

Marshallese Population Accidentally Exposed to
Redioactive Fcllout, report BNL 50424. Upton, NY, Brookhaven National Laboratory, 1975.
3. Conard RA, Larsen PR, Robbins J, et ak

Thyroid Hypofunction Appearing as a Delayed
Manifestation of Accidental Exposure to Radioactive Fallout in a Marshallese Population,
report SM 224/607. Vienna, International

A 20-year Review of Medical Findings in a

Review of Medical Findings in a Marshallese
Population 26 years After Accidental Exposure

to Radioactive Follout, report BNL 51261. Upton,
NY, Brookhaven National Laboratory, January
1981.
.
4. Duffy BJ Jr, Fitzgerald PJ: Cancer of the
thyroid in children: A report of 283 cases. J Clin
Endocrinol 1950;10;:1296-1308.
5. Favus MU, Schneider AB, Stachura ME, et

2): Thyroid cancer occurring 2s a late conse-

quence of head and neck irradiation: Evaluation
of 1,056 patients. N Engl J Med 1976;294:10191025.

thyroid neoplasms after childhood irradiation
for tinea capitis. JNCI 19380;65:7-11.

9. Larsen PR, Conard RA, Knudsen K, et ak:

Atomic Energy Agency, 1978, pp 102-114.
10. Larsen PR: Radioimmunoassay of thyroxine, triiodothyronine, and thyrotropin in human
serum, in Rose NR, Friedman H (eds): Manual of
Clinical Immunology. Washington, DC, Ameriean Society of Microbiology, 1976, pp 222-230.
- 11. Garnick MB, Larsen PR: Acute deficiency
of thyroxine-binding globulin during L-asparaginase therapy. N Engl J Med 1979-301:251-253.
12. James RA: Estimate of radiation dose ta

thyroids of the Rongelap children following the
Bravo event. Univ Calif Rediat Lob publication
12273, December 1964.:

13. Mochizuki Y, Mowafy R, Pasternack B:
Weights of human thyroids in ‘New York City.

Health Phys 1963,9:219-221.
14. Rall JE, Conard RA: Elevation of the
serum protein-bound iodine level in Inhabitants

.

7. Maxon HR, Saenger EL, Thomas SR, et ak

Clinically important radiation-associated thy-

REPOSITORY

BNL

of the Marshall Islands. Am J Med 1966;40-883-

16. Rallison ML, Dobyns BM, Keating JR, et
-al: Thyroid diseases in children: A survey of

. subjects potentially exposed to fallout radiation.
Am J Med 1974;56:457-463,
17. Becker DV, McConahey WM, Dobyns BM,
et ak The results of the thyrotoxicosis therapy
follow-up study, in Fellinger K, Hofer R (eds):

Further Advances in Thyroid Research. Vienna,
Gistel G et Cie, 1971, vol 1, pp 603-607.

18. Thein-Wai W, Larsen PR: Effects of week-

ly thyroxine administration on serum thyroxine,

. and 3,5,3’-triiodothyronine, thyrotrosin, and the
thyrotropin response to thyrotropia-releasing
hormone. J Clin Endocrinol Metab 1980;50:560-

564.

:

19. Book SA, McNeill DA, Parks NJ, et ai:
Comparative effects of iodine-132 and iodine-131
in rat thyroid glands. Radiat Res 1950;81:216-

253.
20. Walinder G, Jonsson C-J, Sjoden A-M:
Dose rate dependentin the goitrogen stimulated

mouse thyroid: A comparative investigation of
the effects of roentgen, "I and '“I irradiation.
Acta Radiol Ther Phys Biol 1972;2:24-36.

+2009 ~ 205

JAMA, March 19, 1982—Vol 247, No. 11

The Medical Resear
ch Center

ISLANDS.

BOXNo, S7EDICAL DEPT

2012564

gland. Am J Med 1977;63:967-978.

RECORDS.

COLLecTION 7ARSHALL
FOLDER

15. Maxon HR, Thomas SR, Saenger EL, et al:
Tonizing irradiation and the induction of clinically significant disease in the human thyroid

8 Ron E, Modan B: Benign and malignant

6. Carroll RG: The relationship of head and
neck irradiation to the subsequent development
of thyroid neoplasms, Semin Nucl Med 1976;
6411-420.

836.

PUBLICATIONS

Brookhaven National
Laboratory
Upton, L, L, New York

Hypothyroidism and Fallout Exposure—tLarsen et al

1575

Select target paragraph3